Cord Blood News 10.22 June 7, 2018 | |
| |
TOP STORYScientists previously established clinically meaningful expansion of regulatory T cells (Tregs) from cord blood which prevented graft-versus-host disease (GvHD) in a xenogenic mouse model and improved with post-expansion fucosylation. In this study, they hypothesized that adoptive therapy with fucosylated Tregs would prevent GvHD at a lower ratio to infused allo-reactive donor T cells. [J Clin Oncol] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)A Revised Road Map for the Commitment of Human Cord Blood CD34-Negative Hematopoietic Stem Cells Investigators developed a prospective ultra-high-resolution purification method by applying two positive markers, CD133 and GPI-80. Using this method, they succeeded in purifying single long-term repopulating CD34− hematopoietic stem cells (HSCs) with self-renewing capability residing at the apex of the human HSC hierarchy from cord blood, as evidenced by a single-cell-initiated serial transplantation analysis. [Nat Commun] Full Article To evaluate the outcomes and prognostic factors following allogeneic hematopoietic cell transplantation (HCT) for adult acute myeloid leukemia (AML) in second complete remission, scientists retrospectively analyzed the Japanese registration data of 1080 adult AML patients in CR2 who had received allogeneic HCT. [Br J Haematol] Abstract Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis Investigators studied and compared the phenotype, cytokine profile, and potential function of human naive CD4+ T cells in umbilical cord and peripheral blood. They found that naive CD4+ T cells, but not memory T cells, expressed high levels of chemokine CXCL8. [J Immunol] Abstract Scientists investigated the anti-fibrotic activity in vivo of human mesenchymal stromal cells obtained from whole umbilical cord (hUC-MSC). hUC-MSC possessed strong in vivo anti-fibrotic activity in a mouse model resembling an immunocompetent human subject affected by inflammatory interstial lung diseases. [PLoS One] Full Article The authors describe a dataset of micro-computed tomography reconstructed scans of the proximal part of 21 tibiae from wild-type mice, osteogenesis imperfecta mice (homozygous oim/oim) and oim/oim mice transplanted with human amniotic fluid stem cells. [Sci Data] Full Article | |
| |
REVIEWSIncorporating Placental Tissue in Cord Blood Banking for Stem Cell Transplantation The authors discuss the possibility to incorporate placental tissue cells in cord blood banking. They discuss clinical trials which are studying safety and efficacy of placenta tissue-derived MSCs in selected diseases, and preclinical studies which have proven their therapeutic properties in other diseases. [Expert Rev Hematol] Abstract Visit our reviews page to see a complete list of reviews in the cord blood research field. | |
| |
INDUSTRY NEWSCord Blood Banking Leader Cryo-Cell Acquires CORD:USE Cord Blood Bank, Inc. Cryo-Cell International, Inc. announced that it has entered into an agreement to acquire substantially all of the assets of CORD:USE Cord Blood Bank, Inc. for a purchase price of $14,000,000 with additional consideration subject to earnouts as set forth in the Asset Purchase Agreement. [Cryo-Cell International, Inc. (GlobeNewswire, Inc.)] Press Release South Florida Stem Cell Cryobank Earns AABB Re-Accreditation Stem Cell Cryobank has been granted AABB Re-Accreditation for Human Stem Cell and Human Cord Blood preservation to be used for therapeutic interventions, according to Dipnarine Maharaj, MD, Medical Director. [Stem Cell Cryobank (PR Newswire Association LLC.)] Press Release | |
| |
POLICY NEWSGo for Launch: A Former Astronaut Becomes Spain’s Science Minister Spain has a ministry of science again—and none other than the first Spanish astronaut is leading it. The new transition government led by socialist Pedro Sánchez announced that Pedro Duque, who visited space twice, will be at the helm of the newly created Ministry for Science, Innovation, and Universities. The announcement was cheered by the Spanish scientific community, which has long suffered from declining budgets and bureaucratic hurdles. [ScienceInsider] Editorial Scientists Fare Poorly in Super Tuesday Primary Vote Science-minded candidates seeking seats in the next U.S. Congress took a drubbing from their Democratic opponents in a raft of primary elections across the country. [ScienceInsider] Editorial Chile, Keen to Become a Knowledge Society, Creates a Ministry of Science Scientists in Chile have welcomed a decision by Congress to create a science ministry. Many researchers hope that a dedicated ministry will give science more prominence and better-coordinated policies—provided the ministry’s budget matches the government’s ambitions to “bring Chile towards an information and knowledge society,” as Gonzalo Blumel, the country’s minister secretary-general of the presidency, put it in a statement issued after the 31 May vote. [ScienceInsider] Editorial
| |
EVENTSNEW 30th EORTC-NCI-AACR Symposium Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Research Associate – Advanced Cell Culture Biology (The University of Manchester) Postdoctoral Fellowship – Myeloid Tumors (St. Jude Children’s Research Hospital) Postdoctoral Positions – Cell Biology (Children’s Hospital of Philadelphia) Postdoctoral Research Scholar – Hematologic Malignancies (Washington University School of Medicine) Postdoctoral Fellow – B-Cell Lymphoma (University of Texas Health Science Center) Postdoctoral Fellow – Hematopoiesis and Leukemia (University of Pennsylvania) Research Fellow – Hematology, Blood Disorders and Stem Cell Biology (New York Blood Center) Postdoctoral Fellow – Molecular and Translational Cancer Biology (Thomas Jefferson University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Cord Blood News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|